Costs of HIV medical care in the era of highly active antiretroviral therapy
Gebo, Kelly A.
Kurzformat
Costs of HIV medical care in the era of highly active antiretroviral therapy / Kelly A. Gebo, Richard E. Chaisson, John G. Folkemer - [Erscheinungsort nicht ermittelbar] , 1999
p. 963-969
-
Bern, UB Medizingeschichte, IMG BAG GR.1700.013
| LEADER | 00000naa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 991000665939705501 | ||
| 005 | 20201225094451.0 | ||
| 008 | 071121s1999 xx 00| | eng|| | ||
| 019 | |a Datenkonversion AIDS Info Doku |5 IDSBB/12.04.2013/B583 | ||
| 035 | |a (swissbib)065182138-41slsp_network | ||
| 035 | |a 065182138 |9 ExL | ||
| 035 | |a (IDSBB)006112450DSV01 | ||
| 035 | |a (EXLNZ-41SLSP_NETWORK)991000665939705501 | ||
| 035 | |a (41SLSP_UBE)99116749557905511 |9 (41SLSP_UBE)99116749557905511 | ||
| 040 | |a BAG |e kids |d CH-ZuSLS | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Gebo, Kelly A. | |
| 245 | 1 | 0 | |a Costs of HIV medical care in the era of highly active antiretroviral therapy |c Kelly A. Gebo, Richard E. Chaisson, John G. Folkemer |
| 264 | 1 | |a [Erscheinungsort nicht ermittelbar] |b [sn] |c 1999 | |
| 300 | |a p. 963-969 | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Erschien auch als Sonderdruck | ||
| 520 | |a OBJECTIVES: In the USA, Medicaid is the principal payer of the health care costs of patients with HIV infection. We wished to determine how the costs to Medicaid of patients in Maryland infected with HIV have changed in the setting of highly active antiretroviral treatment. DESIGN: Observational cohort study. METHODS: Analysis of combined economic and clinical data of patients from the Johns Hopkins HIV Service, the provider of primary and sub-specialty care for a majority of HIV-infected patients in the Baltimore metropolitan region. All patients were enrolled in Medicaid and received care longitudinally in Maryland from 1 January 1995 through 31 December 1997. Monthly Medicaid payments were calculated for all inpatient and outpatient services by fiscal year, CD4 cell count, and use of protease inhibitors. RESULTS: For inpatients with a CD4 cell count £ 50 × 106 cells/l, the total health care average monthly payments remained unchanged ( | ||
| 700 | 1 | |a Chaisson, Richard E. | |
| 700 | 1 | |a Folkemer, John G. | |
| 773 | 0 | |t AIDS |d London : Current Science |g Vol. 13 (1999), S. 963-969 |q 13/1999/963-969 |g yr:1999 |g no:13 |w (IDSBB)000577060DSV01 | |
| 852 | 4 | |b B583 |c 583BA |j IMG BAG GR.1700.013 |9 (41SLSP_UBE)99116749557905511 | |
| 900 | |a IDSIxunikat | ||
| 949 | |c 583BA |p 11 |j IMG BAG GR.1700.013 |b B583 |9 (41SLSP_UBE)99116749557905511 | ||
| 986 | |a (41SLSP_UBE)99116749557905511 |9 (41SLSP_UBE)99116749557905511 | ||
| 990 | |f BAG AIDSDoku |9 LOCAL |9 (41SLSP_UBE)99116749557905511 | ||
Basisinformationen
Signatur:
-
Bern, UB Medizingeschichte, IMG BAG GR.1700.013
Ressourcentyp:
Alte Drucke und Rara
Titel:
Costs of HIV medical care in the era of highly active antiretroviral therapy / Kelly A. Gebo, Richard E. Chaisson, John G. Folkemer
Erscheinungsangaben:
[Erscheinungsort nicht ermittelbar], [sn], 1999
Physische Beschreibung:
-
p. 963-969
Inhalt und innere Ordnung
Inhalt:
-
OBJECTIVES: In the USA, Medicaid is the principal payer of the health care costs of patients with HIV infection. We wished to determine how the costs to Medicaid of patients in Maryland infected with HIV have changed in the setting of highly active antiretroviral treatment. DESIGN: Observational cohort study. METHODS: Analysis of combined economic and clinical data of patients from the Johns Hopkins HIV Service, the provider of primary and sub-specialty care for a majority of HIV-infected patients in the Baltimore metropolitan region. All patients were enrolled in Medicaid and received care longitudinally in Maryland from 1 January 1995 through 31 December 1997. Monthly Medicaid payments were calculated for all inpatient and outpatient services by fiscal year, CD4 cell count, and use of protease inhibitors. RESULTS: For inpatients with a CD4 cell count £ 50 × 106 cells/l, the total health care average monthly payments remained unchanged (
Identifikatoren
Systemnummer:
991000665939705501
Andere Systemnummer:
-
(swissbib)065182138-41slsp_network
-
065182138
-
(IDSBB)006112450DSV01
-
(EXLNZ-41SLSP_NETWORK)991000665939705501
-
(41SLSP_UBE)99116749557905511